CYP2D6 pharmacogenetics and risperidone: reflections after 25 years of research

de Leon Jose; Schoretsanitis Georgios

首页> 外文期刊>Pharmacogenomics >CYP2D6 pharmacogenetics and risperidone: reflections after 25 years of research

【24h】

CYP2D6 pharmacogenetics and risperidone: reflections after 25 years of research

机译：CYP2D6药物遗传学和Risperidone：25年后的思考

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pharmacogenomics》 |2020年第16期|共6页
作者
de Leon Jose; Schoretsanitis Georgios;
展开▼
作者单位

Eastern State Hosp Mental Hlth Res Ctr Lexington KY 40511 USA;

Zucker Hillside Hosp Psychiat Res Northwell Hlth Glen Oaks NY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
CYP3A4; drug interactions; genetics; inflammation; phenotype; renal insufficiency; risperidone blood; pharmacokinetics;

机译：CYP3A4;药物相互作用;遗传学;炎症;表型;肾功能不全;Risperidone血;药代动力学;

相似文献

外文文献
中文文献
专利

1. Reflections on 25 Years of Social Science Research Collaboration in China [J] . Iqbal H. Shah 生殖与避孕：英文版 . 2010,第004期
2. MiRNA-365 and miRNA-520c-3p respond to risperidone treatment in first-episode schizophrenia after a 1 year remission [J] . LIU Sha, YUAN Yan-bo, GUAN Li-li, 中华医学杂志（英文版） . 2013,第014期
3. Sao Paulo Research Conference on ＂Molecular Medicine and Pharmacogenetics＂ sponsored by the IUPHAR Section on Pharmacogenetics [J] . 无中国药理学报：英文版 . 2008,第009期
4. Pharmacogenetics of risperidone: A systematic review of the clinical effects of CYP2D6 polymorphisms [Farmacogenética de la risperidona: Una revisión sistemática de los efectos clínicos de los polimorfismos del CYP2D6] [J] . CartwrightA.L., WilbyK.J., CorriganS., The annals of pharmacotherapy . 2013,第3期

机译：利培酮的药理遗传学：CYP2D6多态性的临床效果的系统评价[利培酮的药理遗传学：CYP2D6多态性的临床效果的系统评价]
5. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients [J] . Mas Sergi, Gasso Patricia, Torra Merce, European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology . 2017,第7期

机译：根据CYP2D6表型的直观药物发生给药，根据CYP2D6表型从基因型外推，在第一集精神病患者的队列中
6. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients [J] . Mas Sergi, Gasso Patricia, Torra Merce, European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology . 2017,第7期

机译：根据CYP2D6表型的直观药物发生给药，根据CYP2D6表型从基因型外推，在第一集精神病患者的队列中
7. Analyzing Design Process - Reflection on 25 Years of Professional Practice [C] . Gon?alo Falc?o International Conference on Human Systems Engineering and Design . 2019

机译：分析设计过程 - 思考25年的专业实践
8. Reflections of Life in Death: An Investigation of Archaeo-Biographies at the Perry Site (1LU25) [D] . Stewart, Ashley Nicole. 2020

机译：死亡的思考 - 对佩里部位的考古传记调查（1LU25）
9. Reflections on 25 Years of Health and Human Rights [O] . Sofia Gruskin 2020

机译：关于健康与人权25年的思考
10. PMH52 A cost utility analysis of CYP2D6 pharmacogenetic guided dosing versus standard dosing of risperidone for treatment of schizophrenia [O] . Yep T., Devine B. 2014

机译：PMH52 CYP2D6药物遗传学指导剂量与标准剂量利培酮治疗精神分裂症的成本效用分析
11. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

CYP2D6 pharmacogenetics and risperidone: reflections after 25 years of research

著录项

相似文献

相关主题

期刊订阅